4-(4-Bromo-3-fluorophenyl)morpholine

Catalog No.: 
ACZABX583
CAS No.: 
279261-83-5
Molecular Formula: 
C10H11BrFNO
Molecular Weight: 
260.11
4-(4-Bromo-3-fluorophenyl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$139.00InquiryInquiry
250mg95%$209.00InquiryInquiry
1g95%$520.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-Bromo-3-fluorophenyl)morpholine
IUPAC Name4-(4-bromo-3-fluorophenyl)morpholine
MDL No.MFCD11040389
Molecular FormulaC10H11BrFNO
Molecular Weight260.11
SMILESFC1=CC(N2CCOCC2)=CC=C1Br
InChI KeyPHEZXWMILXKGQC-UHFFFAOYSA-N
Synonym4-(4-BROMO-3-FLUOROPHENYL)MORPHOLINE;Morpholine, 4-(4-bromo-3-fluorophenyl)-
CAS No.279261-83-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZABX583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOYMH719 route compound structure diagram
    ACOYMH719656-65-5In Stock
  4. Then
  5. ACZABX583 route product structure diagram
    ACZABX583279261-83-5
Inquiry

2. ACZABX583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVBTC317 route compound structure diagram
    ACVBTC3171435-52-5In Stock
  4. Then
  5. ACZABX583 route product structure diagram
    ACZABX583279261-83-5
Inquiry

3. ACZABX583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZABX583 route product structure diagram
    ACZABX583279261-83-5
Inquiry

Comments (0)